BioStock: PHI part of new regenerative medicine alliance
Swedish medtech company Phase Holographic Imaging (PHI) has created a technology development alliance with key industry players: Wake Forest Institute for Regenerative Medicine, BioSpherix, QIAGEN and global analytics company SAS. By creating the AI-based process control tools needed for automated biomanufacturing, cell-based therapies could be manufactured cost-effectively with optimized efficacy and safety. BioStock reached out to PHI’s Product Manager Lisa Lindström to learn more.
Read the full interview with Lisa Lindström on biostock.se.